Glycopyrrolate (Page 4 of 4)

PRINCIPAL DISPLAY PANEL

NDC 70710-1646 -1

Glycopyrrolate Injection, USP

0.4 mg/2 mL

(0.2 mg/mL)

NOT FOR USE IN NEWBORNS

CONTAINS BENZYL ALCOHOL

FOR INTRAMUSCULAR OR

INTRAVENOUS ADMINISTRATION

2 mL Single-Dose Vial

Rx only

Zydus Pharmaceuticals Logo

vial-2ml
(click image for full-size original)

NDC 70710-1646 -7

Glycopyrrolate Injection, USP

0.4 mg/2 mL

(0.2 mg/mL)

NOT FOR USE IN NEWBORNS

CONTAINS BENZYL ALCOHOL

FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION

25 x 2 mL Single-Dose Vials

Rx only

Zydus Pharmaceuticals

carton-2ml
(click image for full-size original)

PRINCIPAL DISPLAY PANEL

NDC 70710-1647 -1

Glycopyrrolate Injection, USP

1 mg/5 mL

(0.2 mg/mL)

NOT FOR USE IN NEWBORNS

CONTAINS BENZYL ALCOHOL

FOR INTRAMUSCULAR OR

INTRAVENOUS ADMINISTRATION

5 mL Multiple-Dose Vial

Rx only

Zydus Pharmaceuticals Logo

vial-5ml
(click image for full-size original)

NDC 70710-1647 -7

Glycopyrrolate Injection, USP

1 mg/5 mL

(0.2 mg/mL)

NOT FOR USE IN NEWBORNS

CONTAINS BENZYL ALCOHOL

FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION

25 x 5 mL Multiple-Dose Vials

Rx only

Zydus Pharmaceuticals

carton-5ml
(click image for full-size original)

PRINCIPAL DISPLAY PANEL

NDC 70710-1648 -1

Glycopyrrolate Injection, USP

4 mg/20 mL

(0.2 mg/mL)

NOT FOR USE IN NEWBORNS

CONTAINS BENZYL ALCOHOL

FOR INTRAMUSCULAR OR

INTRAVENOUS ADMINISTRATION

20 mL Multiple-Dose Vial

Rx only

Zydus Pharmaceuticals Logo

vial-20 ml
(click image for full-size original)

NDC 70710-1648-6

Glycopyrrolate Injection, USP

4 mg/20 mL

(0.2 mg/mL)

NOT FOR USE IN NEWBORNS

CONTAINS BENZYL ALCOHOL

FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION

10 x 20 mL Multiple-Dose Vials

Rx only

Zydus Pharmaceuticals

carton-20ml
(click image for full-size original)
GLYCOPYRROLATE glycopyrrolate injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70710-1645
Route of Administration INTRAMUSCULAR, INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
GLYCOPYRROLATE (GLYCOPYRRONIUM) GLYCOPYRROLATE 0.2 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
BENZYL ALCOHOL 9 mg in 1 mL
HYDROCHLORIC ACID
SODIUM HYDROXIDE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70710-1645-7 25 VIAL in 1 CARTON contains a VIAL (70710-1645-1)
1 NDC:70710-1645-1 1 mL in 1 VIAL This package is contained within the CARTON (70710-1645-7)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA214213 11/18/2021
GLYCOPYRROLATE glycopyrrolate injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70710-1646
Route of Administration INTRAMUSCULAR, INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
GLYCOPYRROLATE (GLYCOPYRRONIUM) GLYCOPYRROLATE 0.2 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
BENZYL ALCOHOL 9 mg in 1 mL
HYDROCHLORIC ACID
SODIUM HYDROXIDE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70710-1646-7 25 VIAL in 1 CARTON contains a VIAL (70710-1646-1)
1 NDC:70710-1646-1 2 mL in 1 VIAL This package is contained within the CARTON (70710-1646-7)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA214213 11/18/2021
GLYCOPYRROLATE glycopyrrolate injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70710-1647
Route of Administration INTRAMUSCULAR, INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
GLYCOPYRROLATE (GLYCOPYRRONIUM) GLYCOPYRROLATE 0.2 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
BENZYL ALCOHOL 9 mg in 1 mL
HYDROCHLORIC ACID
SODIUM HYDROXIDE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70710-1647-7 25 VIAL in 1 CARTON contains a VIAL (70710-1647-1)
1 NDC:70710-1647-1 5 mL in 1 VIAL This package is contained within the CARTON (70710-1647-7)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA214213 11/18/2021
GLYCOPYRROLATE glycopyrrolate injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70710-1648
Route of Administration INTRAMUSCULAR, INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
GLYCOPYRROLATE (GLYCOPYRRONIUM) GLYCOPYRROLATE 0.2 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
BENZYL ALCOHOL 9 mg in 1 mL
HYDROCHLORIC ACID
SODIUM HYDROXIDE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70710-1648-6 10 VIAL in 1 CARTON contains a VIAL (70710-1648-1)
1 NDC:70710-1648-1 20 mL in 1 VIAL This package is contained within the CARTON (70710-1648-6)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA214213 11/18/2021
Labeler — Zydus Pharmaceuticals USA Inc. (156861945)
Registrant — Zydus Pharmaceuticals USA Inc. (156861945)
Establishment
Name Address ID/FEI Operations
Zydus Lifesciences Limited 873671928 MANUFACTURE (70710-1645), MANUFACTURE (70710-1646), MANUFACTURE (70710-1647), MANUFACTURE (70710-1648), ANALYSIS (70710-1645), ANALYSIS (70710-1646), ANALYSIS (70710-1647), ANALYSIS (70710-1648)

Revised: 11/2022 Zydus Pharmaceuticals USA Inc.

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.